BCL2 and neoplasm: Among the possible mechanism at the origin of BCL-2 overexpression, the E3 ubiquitin ligase, F-box only protein 10 (FBXO10), that targets BCL-2 for UPS-mediated degradation, is downregulated in MCL tumor cells.